Rélugolix

Relugolix (737789-87-6) est un médicament utilisé dans le traitement de la maladie.

Relugolix is a highly selective, oral, nonpeptide GnRH antagonist being investigated as a possible prostate cancer treatment. Product Name: Relugolix CAS No.: 737789-87-6 Assay: 99% Specification: CP, EP, In-house, as required Molecular Formula: C29H27F2N7O5S Molecular Weight: 623.63 Shelf Life: 2 Years Package: 25kg/drum